Affiliation:
1. Department of Microbiology, Hospital Prínceps d'Espanya, Ciutot Sanitària i Universitària de Bellvitge, Barcelona, Spain.
Abstract
From January 1988 to December 1994, 66 consecutive blood culture isolates of viridans group streptococci collected from febrile neutropenic cancer patients were tested for antimicrobial susceptibilities by the agar dilution method. The antibiotics studied were erythromycin, clarithromycin, roxithromycin, dirithromycin, azithromycin, josamycin, diacetyl-midecamycin, spiramycin, and quinupristin-dalfopristin. A total of 26 (39.4%) strains were resistant to erythromycin with an MIC range of 0.5 to > 128 micrograms/ml. The strains were classified into three groups according to their penicillin susceptibility: 42 (63.6%) were susceptible, 8 (12.1%) were intermediately resistant, and 16 (24.3%) were highly resistant. The percentages of erythromycin-resistant strains in each group were 23.8, 62.5, and 68.8%, respectively. Streptococcus mitis was the species most frequently isolated (83.3%) and showed the highest rates of penicillin (40%) and erythromycin (43.6%) resistance. MICs of all macrolide antibiotics tested and of quinupristin-dalfopristin were higher for penicillin-resistant strains than for penicillin-susceptible strains. All macrolide antibiotics tested had cross-resistance to erythromycin, which was not observed with quinupristin-dalfopristin. Our study shows a high rate of macrolide resistance among viridans group streptococci isolated from blood samples of neutropenic cancer patients, especially those infected with penicillin-resistant strains. These findings make macrolides unsuitable prophylactic agents against viridans group streptococcal bacteremia in this patient population.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference34 articles.
1. Alcaide F. J. Carratalà J. Liares F. Gudiol and R. Martín. 1995. In vitro activity of eight macrolide antibiotics and RP-59500 against viridans streptococci isolated from blood of neutropenic cancer patients abstr. E51 p. 94. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology Washington D.C.
2. In vitro activities of 22 ~-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood;Alcaide F.;Antimicrob. Agents Chemother.,1995
3. Streptococcal and enterococcal bacteremia in patients with cancer;Awada A.;Clin. Infect. Dis.,1992
4. In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogens;Barry A. L.;Antimicrob. Agents Chemother.,1995
5. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors;Bochud P. Y.;Clin. Infect. Dis.,1994
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献